classifi
mechan
antibiot
failur
led
develop
new
treatment
strategi
kill
bacteria
among
current
describ
mechanismswhich
includ
resist
persist
tolerancew
propos
defianc
subclass
antibiot
failur
specif
prodrug
use
lock
antimicrobi
peptid
amp
activ
bacteri
proteas
prototyp
prodrug
observ
although
treatment
elimin
bacteria
across
vast
major
environment
condit
eg
temperatur
concentr
growth
nutrient
bacteria
spontan
switch
suscept
defianc
condit
alter
compet
rate
bacteri
prolifer
prodrug
activ
identifi
determin
switchlik
behavior
model
bacteriaprodrug
dynam
multir
feedback
system
identifi
dimensionless
quantiti
call
bacteri
advantag
heurist
bah
perfectli
classifi
bacteria
either
defiant
suscept
across
broad
rang
treatment
condit
recogn
bacteri
switch
suscept
defianc
behav
analog
electron
transistor
construct
prodrug
logic
gate
eg
etc
allow
assembl
integr
multiprodrug
circuit
kill
defiant
bacteria
possibl
combin
bah
valu
ie
repres
broad
rang
possibl
treatment
condit
studi
identifi
form
bacteri
resist
specif
prodrug
describ
predict
dimensionless
constant
reveal
logicbas
treatment
strategi
use
multiprodrug
biolog
circuit
rise
multidrugresist
bacteria
coupl
lack
newli
develop
antibiot
creat
seriou
public
health
threat
understand
caus
antibiot
failur
inspir
develop
new
drug
inform
clinic
treatment
strategi
failur
mechan
broadli
classifi
three
distinct
categori
ie
resist
persist
toler
character
chang
drug
concentr
exposur
time
requir
kill
bacteria
exampl
resist
character
genet
mutat
phenotyp
chang
result
bacteria
requir
significantli
higher
concentr
antibiot
minimum
inhibitori
concentr
mic
lethal
contrast
bacteria
exhibit
toler
persist
requir
increas
drug
exposur
time
minimum
durat
kill
mdk
latter
exhibit
biphas
kill
profil
fig
bacteria
popul
becom
toler
environment
condit
genet
mutat
wherea
persist
activ
maintain
nonherit
state
exhibit
subpopul
bacteria
discrimin
surviv
strategi
employ
bacteria
crucial
develop
new
drug
clinic
treatment
decis
antibiot
success
markedli
improv
proper
titrat
drug
overdos
lead
offtarget
toxic
underdos
increas
likelihood
pathogen
develop
resist
howev
optim
drug
dose
difficult
achiev
cours
treatment
infect
burden
chang
dynam
time
creat
move
target
prodrug
repres
fdaapprov
drug
last
decad
promis
solut
may
automat
titrat
diseaserel
activ
mechan
increas
bioavail
reduc
risk
offtarget
effect
exampl
prodrug
ganciclovir
isoniazid
administ
biolog
inact
form
enzymat
activ
pathogen
use
prototyp
autotitr
prodrug
compris
cation
antimicrobi
peptid
amp
evolv
part
innat
immun
display
spectrum
prokaryotespecif
antimicrobi
activ
cation
amp
act
disrupt
bacteri
membran
induc
inflammatori
respons
suffer
offtarget
toxic
low
stabil
vivo
amp
prodrug
activ
directli
bacteri
proteas
major
caus
virul
infect
import
target
antibiot
develop
proteas
outer
membran
proteas
ompt
membranebound
bacteri
protein
wide
conserv
across
gramneg
bacteria
enterobacteriacea
famili
recogn
varieti
target
contribut
virul
eg
plasminogen
work
design
cation
amp
lock
charg
complex
anion
peptid
connect
proteasecleav
linker
substrat
recogn
e
coli
proteas
ompt
increas
concentr
bacteria
activ
higher
concentr
free
drug
amp
prodrug
elimin
major
bacteria
observ
bacteria
popul
exhibit
phenotyp
name
defiant
prolifer
presenc
activ
drug
consist
outpac
prodrug
activ
stage
growth
ie
log
phase
stationari
phase
understand
mechan
bacteria
becom
resist
amp
prodrug
built
system
coupl
ordinari
differenti
equat
ode
model
dynam
bacteriaprodrug
competit
use
model
identifi
dimensionless
quantityth
bacteri
advantag
heurist
bah
predict
perfect
accuraci
whether
bacteria
becom
defiant
broad
rang
environment
condit
low
bah
valu
bacteria
suscept
elimin
beyond
critic
bah
threshold
bacteria
switch
state
defianc
bacteria
prolifer
presenc
activ
drug
combat
prodrug
failur
due
defianc
design
biolog
circuit
elimin
bacteria
condit
bah
valu
recogn
amp
prodrug
behav
analog
transistor
critic
bah
threshold
ie
gate
voltag
bacteria
ie
input
current
pass
prodrug
exhibit
defianc
use
framework
build
logic
gate
prodrug
transistor
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
use
construct
multiprodrug
circuit
output
ie
dead
bacteria
eight
combin
three
input
bah
valu
quantit
mechanist
insight
inform
futur
drug
design
treatment
protocol
combat
antibiot
resist
construct
bacteriaactiv
prodrug
synthes
cation
polyarginin
amp
charg
complex
anion
peptid
lock
polyglutam
acid
linker
peptid
rrsrrv
specif
ubiquit
bacteri
proteas
ompt
upon
proteolyt
cleavag
linker
hairpin
prodrug
unlock
releas
free
amp
creat
mechan
autotitr
fig
demonstr
linker
specif
ompt
synthes
activ
probe
free
linker
peptid
contain
fluorophorequench
pair
detect
ompt
activ
sampl
incub
recombin
ompt
live
e
coli
cultur
convers
observ
activ
sampl
contain
serin
proteas
inhibitor
aprotinin
inhibit
ompt
present
micromolar
concentr
fig
observ
similar
cleavag
activ
use
linker
substrat
fulli
integr
hairpin
amp
druglock
complex
confirm
linker
present
within
constrain
conform
state
affect
cleavag
activ
ompt
fig
measur
cytotox
unlock
drug
dose
bacteria
free
amp
observ
signific
reduct
coloni
compar
untreat
control
blue
bar
fig
f
confirm
prodrug
specif
synthes
amp
druglock
complex
use
linker
peptid
specif
ompt
tobacco
etch
viru
proteas
tev
exhibit
orthogon
proteas
specif
observ
elimin
bacteria
sampl
contain
omptspecif
amp
prodrug
grey
bar
sampl
treat
tev
tevspecif
amp
prodrug
red
bar
control
sampl
contain
either
tevspecif
prodrug
alon
aprotinin
inhibitor
significantli
reduc
bacteria
load
fig
f
tabl
result
show
amp
druglock
complex
inert
lack
cytotox
activ
activ
proteas
activ
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ompt
express
surfac
e
coli
right
fluoresc
label
hairpin
prodrug
blue
line
hairpin
prodrug
control
grey
line
shade
repres
standard
deviat
n
cleavag
assay
plot
fold
chang
rfu
initi
time
point
e
bacteria
viabil
assay
quantifi
drug
toxic
rel
untreat
bacteria
control
blue
bar
posit
control
amp
toxic
black
bar
neg
control
lock
amp
tev
proteas
alon
tan
bar
posit
control
tev
proteas
lock
amp
substrat
enlyfqg
specif
tev
proteas
red
bar
neg
control
lock
amp
substrat
rrsrrv
specif
ompt
repres
imag
bacteri
plate
use
quantifi
viabil
schemat
legend
scale
bar
mm
quantit
understand
rate
prodrug
activ
compet
number
live
bacteria
built
mathemat
model
use
system
nonlinear
ordinari
differenti
equat
ode
system
three
dynam
popul
bacteria
b
lock
drug
l
unlock
drug
u
formul
govern
ode
consid
system
paramet
affect
popul
chang
time
prodrug
system
increas
e
coli
growth
result
increas
proteolyt
activ
amp
turn
lyse
bacteria
creat
neg
feedback
loop
therefor
model
bacteria
popul
b
increas
ie
green
dash
arrow
rate
enzymat
drug
convers
ie
l
u
unlock
drug
popul
u
increas
rate
bacteri
death
fig
account
fact
bacteri
growth
rate
r
slow
environment
resourc
becom
limit
ie
carri
capac
bmax
use
logist
growth
model
produc
sshape
curv
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
use
extens
biolog
studi
popul
expans
tumor
growth
assum
system
constitut
wellmix
solut
freeli
diffus
substrat
ie
lock
drug
larg
excess
valid
assumpt
studi
sinc
amp
prodrug
present
concentr
micromolar
aqueou
environ
total
amount
drug
conserv
defin
mm
activ
rate
unlock
drug
u
opposit
degrad
rate
lock
drug
l
equat
includ
term
account
loss
activ
amp
accord
proportion
constant
repres
number
amp
requir
kill
one
e
coli
term
necessari
amp
lyse
e
coli
intercal
bacteri
membran
therefor
remov
system
unabl
target
addit
bacteria
fit
model
system
measur
valu
relev
paramet
includ
enzymat
effici
eg
kcat
km
bacteri
growth
eg
r
bmax
prodrug
activ
eg
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
fig
tabl
allow
us
predict
bacteriaprodrug
respons
curv
red
blue
dash
line
fig
across
nine
distinct
combin
kcat
r
valu
experiment
control
alter
ambient
temperatur
concentr
broth
condit
label
tabl
strikingli
model
anticip
binari
bacteri
respons
prodrug
treatment
would
evid
within
hour
bacteria
predict
either
suscept
prodrug
die
red
dash
line
exhibit
druginvari
phenotyp
prolifer
satur
level
blue
dash
line
fig
c
experiment
valid
model
predict
incub
bacteria
prodrug
defin
nine
condit
quantifi
number
live
bacteria
longitudin
cours
hour
treatment
window
quantifi
bacteri
count
taken
cours
treatment
well
endpoint
close
match
valu
predict
model
r
red
blue
dot
fig
c
likewis
reveal
binari
bacteri
respons
prodrug
lead
antibiot
failur
therefor
call
form
resist
prodrug
bacteri
defianc
collect
experi
demonstr
e
coli
expos
amp
prodrug
model
use
predict
bacteri
growth
kinet
ultim
result
binari
outcom
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
schemat
depict
bacteri
defianc
character
prolifer
presenc
activ
drug
demonstr
bacteria
expos
prodrug
exhibit
binari
outcomesuscept
ie
death
defianc
ie
surviv
next
sought
determin
whether
behavior
could
quantifi
metric
resist
could
gener
across
broad
treatment
condit
base
model
experiment
valid
observ
defianc
popul
live
bacteria
expand
ie
posit
growth
rate
throughout
cours
treatment
impli
key
bacteri
growth
paramet
eg
r
bmax
greater
valu
enzymedriven
death
rate
paramet
eg
kcat
km
fig
therefor
deriv
metric
discrimin
defiant
suscept
bacteria
use
buckingham
pi
theorem
identifi
dimensionless
quantiti
repres
compet
balanc
growth
rate
enzymat
turnov
defin
bacteri
advantag
heurist
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
quantiti
reflect
bacteria
higher
probabl
switch
defianc
phenotyp
condit
promot
faster
growth
rate
r
slower
enzymat
activ
kcat
predict
onset
defianc
phenotyp
sought
determin
critic
bah
valu
distinguish
defiant
bacteria
suscept
popul
use
mathemat
model
simul
prodrug
treatment
condit
cover
rang
valu
r
bmax
kcat
km
identifi
critic
valu
bah
bacteria
switch
suscept
defianc
bahcrit
fig
word
environment
genet
condit
produc
bah
bahcrit
bacteria
surviv
prodrug
treatment
bah
bahcrit
bacteria
die
test
robust
switchlik
behavior
model
treatment
outcom
vari
bacteri
growth
rate
r
enzymat
effici
kcat
point
found
bahcrit
timeindepend
across
rang
prodrug
treatment
durat
fig
addit
demonstr
bahcrit
independ
system
paramet
model
treatment
outcom
point
individu
fix
four
paramet
ie
r
bmax
kcat
km
turn
found
bahcrit
invari
across
condit
test
fig
confirm
valu
bahcrit
experiment
first
use
nine
experiment
condit
previous
test
fit
valu
kcat
r
fig
use
computationallyderiv
critic
bah
threshold
classifi
phenotyp
nine
bacteriaprodrug
treatment
condit
receiveroperatingcharacterist
roc
analysi
bahcrit
perfectli
predict
onset
defianc
fig
k
auroc
n
specif
sensit
model
result
predict
chang
key
system
paramet
decreas
bah
critic
threshold
result
success
treatment
defiant
bacteria
demonstr
took
three
differ
amp
prodrug
distinct
linker
sequenc
tabl
increas
kcat
valu
ompt
decreas
bah
bahcrit
allow
us
success
treat
previous
defiant
popul
bacteria
fig
find
import
success
design
administr
prodrug
therapi
may
improv
optim
fundament
pharmacokinet
paramet
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
model
reveal
bacteri
defianc
aris
prodrug
monotherapi
environment
paramet
repres
dimensionless
constant
cross
critic
transit
bah
valu
combat
bacteri
defianc
therefor
sought
design
multiprodrug
approach
elimin
defiant
bacteria
would
otherwis
resist
treatment
singl
prodrug
fig
recogn
bacteri
switch
suscept
defianc
could
consid
behav
analog
electron
transistorstransistor
allow
input
current
iin
pass
iout
gate
voltag
g
cross
threshold
wherea
amp
prodrug
input
bacteria
bin
surviv
treatment
bout
bah
gate
cross
critic
valu
fig
analog
postul
multipl
prodrug
biolog
transistor
could
use
construct
logic
oper
ie
gate
allow
design
integr
biolog
circuit
output
state
ie
bacteri
death
possibl
input
biolog
circuit
would
repres
multiprodrug
strategi
elimin
bacteria
even
input
bah
variabl
ie
temperatur
nutrient
level
enzym
activ
would
result
state
defianc
singl
prodrug
accomplish
design
complementari
ntype
ptype
transistor
requir
construct
possibl
logic
gate
ntype
transistor
allow
input
current
pass
gate
signal
defin
threshold
wherea
ptype
transistor
allow
current
pass
gate
signal
defin
threshold
construct
ntype
transistor
amp
prodrug
system
allow
input
bacteria
bin
surviv
bout
bah
bahcrit
use
defin
gate
threshold
ie
bah
bahcrit
equival
g
bah
bahcrit
equival
g
fig
creat
ptype
transistor
synthes
heattrigg
liposom
fig
load
antibiot
ampicillin
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
releas
temperatur
c
kill
bacteria
ie
bout
fig
critic
temperatur
treatment
amp
prodrug
lead
bacteri
defianc
ie
bah
bahcrit
g
e
coli
surviv
prodrug
treatment
prolifer
significantli
faster
prodrug
activ
therefor
defin
temperatur
c
correspond
g
g
ptype
biolog
transistor
match
invers
gate
valu
ntype
biolog
transistor
result
demonstr
antimicrobi
drug
could
model
similar
input
output
characterist
compar
ntype
ptype
transistor
heattrigg
drugload
liposom
allow
input
bacteria
bin
surviv
bout
gate
signal
g
low
ie
g
temperatur
tcrit
truth
tabl
depict
binari
inputoutput
combin
demonstr
use
multipl
prodrug
transistor
biolog
circuit
capabl
kill
defiant
bacteria
select
three
variabl
ie
bacteri
nutrient
temperatur
linker
substrat
kcat
independ
influenc
bacteriaprodrug
competit
act
circuit
input
ie
b
c
respect
circuit
input
assign
valu
fix
variabl
choos
one
condit
enabl
bacteri
surviv
ie
bah
bahcrit
one
condit
result
bacteri
death
ie
bah
bahcrit
design
biolog
circuit
kill
bacteria
ie
eight
combin
nutrient
lb
broth
temperatur
c
c
linker
substrat
kcat
x
x
condit
use
three
gate
one
gate
fig
electron
gate
creat
place
two
transistor
seri
similarli
sequenti
dose
bacteria
two
prodrug
correspond
bah
valu
repres
gate
input
ie
b
control
correspond
bah
valu
prodrug
linker
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
substrat
sequenc
eg
b
kcat
x
b
kcat
x
test
four
combin
two
prodrug
ie
ab
expos
four
possibl
input
bacteria
surviv
condit
two
low
kcat
prodrug
ie
ab
match
ideal
output
gate
fig
result
show
dose
multipl
prodrug
sequenc
reduc
fraction
bacteri
popul
surviv
eg
one
prodrug
surviv
two
prodrug
surviv
etc
wherea
gate
compris
prodrug
seri
demonstr
one
implement
gate
split
popul
bacteria
half
ie
separ
well
dose
differ
prodrug
time
interv
ie
parallel
recombin
bacteria
posttreat
use
circuit
bacteria
surviv
case
least
one
half
popul
dose
low
kcat
prodrug
ie
ab
match
ideal
output
gate
fig
creat
gate
use
ptype
transistor
compris
ampicillinload
heattrigg
liposom
caus
bacteria
die
high
temperatur
ie
surviv
low
temperatur
ie
fig
result
show
heattrigg
liposom
use
failsaf
kill
bacteria
critic
temperatur
repres
onset
defianc
phenotyp
valid
multiprodrug
circuit
incub
popul
bacteria
eight
environment
condit
three
prodrug
amp
prodrug
fix
kcatkm
amp
prodrug
kcatkm
determin
input
c
heattrigg
drugload
liposom
fig
wherea
singl
prodrug
elimin
bacteria
half
input
case
fig
circuit
autonom
elimin
bacteria
eight
combin
three
environment
signal
fig
result
demonstr
util
transistorlik
properti
prodrug
design
administ
biocircuit
combat
bacteri
defianc
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
environment
condit
e
bacteri
viabil
assay
demonstr
eight
output
autonom
circuit
f
repres
cfu
imag
singl
prodrug
multiprodrug
treatment
scale
bar
mm
error
bar
repres
standard
deviat
n
rise
threat
antibiot
failur
motiv
classif
resist
mechan
improv
design
futur
treatment
strategi
work
identifi
prodrugspecif
subclass
resist
name
defianc
studi
bacteri
defianc
synthes
amp
prodrug
activ
bacteri
proteas
activ
success
kill
e
coli
howev
found
prodrug
fail
condit
bacteria
grew
faster
rate
activ
drug
develop
mathemat
model
bacteriaprodrug
competit
deriv
dimensionless
constant
bah
use
perfectli
predict
onset
defianc
phenotyp
studi
reveal
environment
eg
temperatur
avail
nutrient
pharmacokinet
eg
activ
rate
kcat
paramet
tune
engin
success
prodrug
therapi
futur
work
inform
could
leverag
improv
efficaci
exist
prodrug
tune
prodrug
decay
constant
ie
biolog
halflif
directli
chang
bahcrit
valu
altern
catalyt
effici
prodrug
substrat
could
tune
chang
bah
valu
increas
probabl
success
previous
demonstr
engin
prodrug
substrat
higher
affin
enzymat
target
studi
insight
bacteri
defianc
elucid
context
amp
prodrug
activ
extracellular
mechan
action
anticip
phenomenon
defianc
also
extend
prodrug
intracellularli
activ
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
repres
second
major
categori
prodrug
account
intracellular
activ
model
would
includ
transport
rate
term
account
prodrug
diffus
across
cell
membran
implic
model
like
still
hold
prodrug
transport
rate
limit
step
ie
repres
separ
mechan
bacteria
escap
treatment
greater
rate
prodrug
activ
reason
assumpt
given
rate
drug
diffus
across
membran
order
fold
higher
typic
rang
prodrug
activ
rate
comparison
establish
form
resist
prodrug
defianc
could
occur
either
genet
phenotyp
chang
exampl
phenotyp
resist
ie
noninherit
resist
toler
acquir
specif
condit
affect
growth
rate
biofilm
contrast
inherit
resist
aris
genet
mutat
alter
key
bacteri
process
includ
metabol
enzymat
activ
drug
efflux
pump
studi
demonstr
environment
condit
ie
temperatur
nutrient
level
affect
defianc
phenotyp
howev
also
like
onset
defianc
could
also
aris
genet
mutat
affect
e
coli
growth
rate
cleavag
activ
proteas
find
suggest
prodrug
current
use
clinic
may
fail
due
onset
bacteri
defianc
exampl
nitroimidazol
class
antibiot
eg
metronidazol
dimetridazol
tinidazol
etc
use
treat
anaerob
bacteria
eg
enterococcu
speci
clostridium
speci
helicobact
pylori
etc
repres
prodrug
activ
bacteri
reductas
genet
studi
reveal
bacteri
resist
nitroimidazol
antibiot
caus
either
partial
complet
reduct
express
gene
eg
rdxa
frxa
etc
encod
reductas
activ
prodrug
chang
activ
enzym
would
decreas
rate
prodrug
activ
therebi
result
reduc
overal
bah
bahcrit
system
would
result
defianc
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
bacteriaactiv
prodrug
emerg
strategi
treat
antibiot
resist
infect
work
may
provid
strategi
prevent
defiancerel
resist
mechan
new
exist
prodrug
propos
strategi
treat
prodrug
defianc
leverag
transistorlik
behavior
prodrug
design
multidrug
circuit
elimin
defiant
bacteria
would
normal
surviv
treatment
singl
prodrug
experi
test
eight
discret
combin
three
variabl
eg
nutrient
temperatur
linker
substrat
show
multidrug
logic
circuit
effect
elimin
bacteria
eight
condit
futur
work
differ
variabl
eg
ph
rel
biodistribut
etc
could
includ
increas
rang
possibl
treatment
condit
would
requir
quantit
understand
relationship
variabl
affect
key
compon
bah
ie
r
kcat
ideal
variabl
proport
influenc
either
growth
rate
enzymat
activ
bacteria
increas
substrat
effici
increas
kcat
creat
one
critic
valu
bahcrit
contrast
variabl
influenc
growth
rate
enzym
activ
multipl
critic
valu
ie
inflect
point
limit
rang
applic
exampl
higher
temperatur
increas
growth
rate
enzymat
activ
critic
temperatur
protein
enzym
denatur
result
irrevers
loss
activ
howev
valu
beyond
relev
biolog
valu
limit
applic
prodrug
treatment
normal
physiolog
condit
quantit
studi
mechan
prodrug
defianc
reveal
logicbas
strategi
success
treat
bacteria
envis
bodi
work
motiv
develop
new
prodrug
improv
clinic
administr
exist
prodrug
ultim
help
reduc
burden
antibiot
failur
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
measur
drug
cytotox
quantifi
percent
viabl
bacteria
expos
unlock
amp
drug
dose
rang
nanomolar
millimolar
concentr
observ
spike
cytotox
micromolar
rang
fig
calcul
bacteri
growth
rate
constant
incub
bacteria
broth
water
c
measur
cours
hour
reveal
higher
growth
rate
broth
consist
publish
valu
h
fig
quantifi
enzymat
veloc
measur
proteolyt
veloc
mole
l
substrat
concentr
rang
um
fit
michaelismenten
equat
data
calcul
kcat
km
fig
use
measur
paramet
tabl
gener
kinet
curv
bacteria
number
drug
concentr
time
model
show
period
initi
bacteri
growth
lag
drug
popul
elimin
infect
burden
initi
reservoir
lock
drug
concentr
unlock
drug
never
rose
fig
reveal
system
maintain
minim
drug
concentr
requir
kill
infect
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
estim
bacteri
growth
rate
r
enzymat
activ
kcat
use
paramet
fit
method
simplifi
model
without
prodrug
fig
model
prodrug
substitut
fluoresc
probe
p
activ
substrat
sequenc
amp
prodrug
simplifi
model
defin
one
bacterium
ompt
proteas
per
cell
equival
one
effect
enzym
concentr
cleav
fluoresc
probe
monitor
time
bacteri
concentr
quantifi
serial
time
point
fit
data
two
equat
model
bacteri
growth
activ
fluoresc
probe
equat
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ompt
probe
dabcylrrsrrvli
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
